Why is Evoq Remedies falling/rising?

As of 18-Sep, Evoq Remedies Ltd is currently priced at 3.58, showing no change (0.00%). The stock has underperformed its sector today by 1.05% and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 2.72%, and it has experienced significant losses over the past month and year, with returns of -10.05% and -59.59%, respectively. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 81.48% compared to the 5-day average, indicating a lack of interest from investors. There are no positive or negative factors available to further explain the stock's recent movement.
In the broader market context, Evoq Remedies' performance has been significantly weaker than the benchmark, the Sensex, which has gained 1.80% over the past week. The stark contrast is evident in the year-to-date returns, where Evoq Remedies has plummeted by 54.10%, while the Sensex has increased by 6.24%. This underperformance relative to the benchmark suggests that the stock is struggling to attract investor confidence, contributing to its declining price trend.